Page last updated: 2024-09-03

calpain inhibitor 2 and Leukemia, Lymphocytic, Chronic, B-Cell

calpain inhibitor 2 has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bryl, E; Daca, A; Frąckowiak, J; Fulop, T; Hellmann, A; Mikosik, A; Mital, A; Puchalska, Z; Witkowski, JM; Łopatniuk, P1

Other Studies

1 other study(ies) available for calpain inhibitor 2 and Leukemia, Lymphocytic, Chronic, B-Cell

ArticleYear
Excessive amount and activity of μ-calpain affects apoptotic machinery in chronic B-cell leukemia cells and influences the course of the disease.
    Acta biochimica Polonica, 2020, Jun-16, Volume: 67, Issue:2

    Topics: Aged; Aged, 80 and over; Apoptosis; B-Lymphocytes; Calpain; Case-Control Studies; Caspase 3; Caspase 9; Cells, Cultured; Disease Progression; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm Staging; Oligopeptides; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; ZAP-70 Protein-Tyrosine Kinase

2020